Publications
239
Citations
14,571
Est. group size
—
Recurring co-author estimate
Active years
57
Publishing since 1969
Typically publishes in teams of ~11 · 13% small-team papers (≤3 authors) · across 32 venues
- Effects of Finerenone on Natriuretic Peptide Levels in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Trial
European Journal of Heart Failure · 2025
- Mineralocorticoid Receptor Antagonists and Aldosterone Synthase Inhibitors: Agent Comparison With Implications for Clinical Practice and Trial Design
Journal of Cardiac Failure · 2025
- Efficacy and Tolerability of Finerenone According to the Use and Dosage of Diuretics
JAMA Cardiology · 2025
- Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection Fraction According to Body Weight
European Journal of Heart Failure · 2025
- Efficacy and Safety of Finerenone in Asian Patients with Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis
Kidney Diseases · 2025
- Interaction Between Aldosterone and Mineralocorticoid Receptor Antagonist
JACC Heart Failure · 2025
- Blinded Withdrawal of Finerenone After Long-Term Treatment in the FINEARTS-HF Trial
Journal of the American College of Cardiology · 2025
- Finerenone Efficacy in Patients with Chronic Kidney Disease, Type 2 Diabetes, and Anemia in FIDELITY
JACC Advances · 2025
- Temporal Changes in Biomarkers, Functional Status, and Quality of Life Prior to Adverse Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
JACC Heart Failure · 2025
- An Individual Treatment Effect Approach to Predict Response to Mineralocorticoid Receptor Antagonists in Patients with Heart Failure and Reduced Ejection Fraction
European Journal of Heart Failure · 2025
- Effects of Finerenone on Readmissions for Heart Failure: Insights From the FINEARTS-HF Trial
Journal of Cardiac Failure · 2025
- Hyperkalemia Risk And The Effect Of Finerenone In Patients With Diabetes And Chronic Kidney Disease: An Analysis From Fidelity
Journal of Cardiac Failure · 2025
- WCN25-288 EFFECT OF FINERENONE TREATMENT DISCONTINUATION ON KIDNEY AND CV OUTCOMES IN PATIENTS WITH CKD AND T2D: A FIDELITY SUBANALYSIS
Kidney International Reports · 2025
- #2198 Effect of finerenone on eGFR slope across different levels of baseline albuminuria: insights from FINEARTS-HF
Nephrology Dialysis Transplantation · 2025
- Abstract 4366830: Symptoms of Bladder Incontinence Are Associated with Worse Functional Status and Quality of Life in Heart Failure with Preserved Ejection Fraction
Circulation · 2025
- European Journal of Heart Failure×18
- Circulation Heart Failure×9
- JACC Heart Failure×9
- Circulation×9
- European Heart Journal×7
- Bertram Pitt
Medicine · University of Michigan
- Bertram Pitt
Medicine · University of Michigan
- Bertram Pitt
Medicine · University of Michigan
- Phillip D. Levy
Medicine · University of Michigan
- Chris Watson
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile